Boryana Marinkova, Bulgarian Association of Medicines Parallel Trade Development (BAMPTD) CEO, Investor Club, 24.08.2019.
Economical overregulation of medicines could be reviewed to address at least part of the problem of drug shortages in our country due to the withdrawal of certain drugs for market reasons. This was commented by Boryana Marinova, Bulgarian Association of Medicines Parallel Trade Development (BAMPTD) CEO, on the program "Investor Club" hosted by Ivaylo Lakov.
"Overregulation from a safety standpoint is mandatory. In terms of economic conditions, it could be revised to make the Bulgarian market a little more attractive for both international companies and local businesses. "
Our country suffers from the lack of rhythmic regular predictable deliveries, which is an EU-wide problem, Marinkova commented.